<?xml version="1.0" encoding="UTF-8"?><mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="id-2014-30011">
    <name type="corporate">
        <namePart>United States Government Publishing Office</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
            <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
        <role>
            <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
            <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>National Archives and Records Administration</namePart>
        <namePart>Office of the Federal Register</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">author</roleTerm>
            <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
        <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
        <collectionCode>FR</collectionCode>
        <category>Regulatory Information</category>
        <waisDatabaseName>2014_register</waisDatabaseName>
        <branch>executive</branch>
        <dateIngested>2014-12-23</dateIngested>
    </extension>
    <genre authority="marcgt">article</genre>
    <titleInfo>
        <title>Minimal Manipulation of Human Cells, Tissues, and Cellular- and Tissue-Based Products; Draft Guidance for Industry and Food and Drug Administration Staff; Availability</title>
        <partName>Notices</partName>
    </titleInfo>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2014-12-23/html/2014-30011.htm">
        <identifier type="FDsys Unique ID">D09002ee1c7f81caf</identifier>
    </relatedItem>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2014-12-23/pdf/2014-30011.pdf">
        <identifier type="FDsys Unique ID">D09002ee1c7f81d47</identifier>
    </relatedItem>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Department of Health and Human Services</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Food and Drug Administration</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <abstract>The Food and Drug Administration (FDA) is announcing the availability of a draft document entitled "Minimal Manipulation of Human Cells, Tissues, and Cellular- and Tissue-Based Products; Draft Guidance for Industry and Food and Drug Administration Staff." The draft guidance document provides human cells, tissues, and cellular- and tissue-based product (HCT/P) manufacturers, healthcare providers, and FDA staff with recommendations for meeting the criterion of "minimal manipulation" as it applies to HCT/Ps. The draft guidance, when finalized, is intended to supersede the document entitled "Guidance for Industry and FDA Staff: Minimal Manipulation of Structural Tissue Jurisdictional Update" dated September 2006. This draft guidance is not final nor is it in effect at this time.</abstract>
    <identifier type="FR citation">79 FR 77012</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/FR-2014-12-23/2014-30011</identifier>
    <identifier type="FR Doc No.">2014-30011</identifier>
    <identifier type="former granule identifier">fr23de14-73</identifier>
    <identifier type="billing code">4164-01-P</identifier>
    <identifier type="department code">Docket No. FDA-2014-D-1696</identifier>
    <location>
        <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2014-12-23/2014-30011</url>
        <url access="raw object" displayLabel="HTML rendition">https://www.govinfo.gov/content/pkg/FR-2014-12-23/html/2014-30011.htm</url>
        <url access="raw object" displayLabel="PDF rendition">https://www.govinfo.gov/content/pkg/FR-2014-12-23/pdf/2014-30011.pdf</url>
    </location>
    <physicalDescription>
        <extent>2 p.</extent>
    </physicalDescription>
    <part type="Notices">
        <extent unit="pages">
            <start>77012</start>
            <end>77013</end>
        </extent>
    </part>
    <identifier type="preferred citation">79 FR 77012</identifier>
    <extension>
        <searchTitle>Minimal Manipulation of Human Cells, Tissues, and Cellular- and Tissue-Based Products; Draft Guidance for Industry and Food and Drug Administration Staff; Availability; Federal Register Vol. 79, Issue </searchTitle>
        <granuleClass>NOTICE</granuleClass>
        <accessId>2014-30011</accessId>
        <agency order="1">DEPARTMENT OF HEALTH AND HUMAN SERVICES</agency>
        <agency order="2">Food and Drug Administration</agency>
        <departmentDoc>Docket No. FDA-2014-D-1696</departmentDoc>
        <billingCode>4164-01-P</billingCode>
        <frDocNumber>2014-30011</frDocNumber>
        <action>Notice.</action>
        <summary>The Food and Drug Administration (FDA) is announcing the availability of a draft document entitled "Minimal Manipulation of Human Cells, Tissues, and Cellular- and Tissue-Based Products; Draft Guidance for Industry and Food and Drug Administration Staff." The draft guidance document provides human cells, tissues, and cellular- and tissue-based product (HCT/P) manufacturers, healthcare providers, and FDA staff with recommendations for meeting the criterion of "minimal manipulation" as it applies to HCT/Ps. The draft guidance, when finalized, is intended to supersede the document entitled "Guidance for Industry and FDA Staff: Minimal Manipulation of Structural Tissue Jurisdictional Update" dated September 2006. This draft guidance is not final nor is it in effect at this time.</summary>
        <dates>Although you can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the Agency considers your comment on this draft guidance before it begins work on the final version of the guidance, submit either electronic or written comments on the draft guidance by February 23, 2015.</dates>
        <contact>Melissa Segal, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 7301, Silver Spring, MD 20993-0002, 240- 402-7911, or Angela Krueger, Office of Device Evaluation, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 1666, Silver Spring, MD 20993-0002, 301-796-6380, or Leigh Hayes, Office of Combination Products, Office of the Commissioner, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Hub 5129, Silver Spring, MD 20993-0002, 301-796-8938.</contact>
        <tocSubject1>Guidance:</tocSubject1>
        <tocDoc>Minimal Manipulation of Human Cells, Tissues, and Cellular- and Tissue-Based Products
, </tocDoc>
        <emailRef>CDRH-guidance@fda.hhs.gov</emailRef>
        <emailRef>combination@fda.gov</emailRef>
        <urlRef>http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm</urlRef>
        <urlRef>http://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/default.htm</urlRef>
        <urlRef>http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/default.htm</urlRef>
        <urlRef>http://www.regulations.gov</urlRef>
    </extension>
    <relatedItem type="host" ID="P0b002ee18a815f68" xlink:href="https://www.govinfo.gov/metadata/pkg/FR-2014-12-23/mods.xml">
        <titleInfo>
            <title>Federal Register</title>
            <partNumber>Vol. 79, no. 246</partNumber>
        </titleInfo>
        <originInfo>
            <publisher>Office of the Federal Register, National Archives and Records Administration</publisher>
            <dateIssued encoding="w3cdtf">2014-12-23</dateIssued>
            <issuance>continuing</issuance>
            <frequency>daily</frequency>
        </originInfo>
        <physicalDescription>
            <note type="source content type">deposited</note>
            <digitalOrigin>born digital</digitalOrigin>
            <extent>504 p.</extent>
        </physicalDescription>
        <tableOfContents xlink:href="https://www.govinfo.gov/app/frtoc/2014-12-23">    
		  Table of Contents: 
		</tableOfContents>
        <classification authority="sudocs">AE 2.7:</classification>
        <classification authority="sudocs">GS 4.107:</classification>
        <classification authority="sudocs">AE 2.106:</classification>
        <classification authority="lcc">KF70.A2</classification>
        <identifier type="uri">https://www.govinfo.gov/app/details/FR-2014-12-23</identifier>
        <identifier type="local">P0b002ee18a815f68</identifier>
        <identifier type="issn">0097-6326</identifier>
        <identifier type="issn">0042-1219</identifier>
        <identifier type="issn">0364-1406</identifier>
        <identifier type="stock number">769-004-00000-9</identifier>
        <identifier type="ILS system id">000582072</identifier>
        <identifier type="former identifier">f:fr23de14</identifier>
        <location>
            <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2014-12-23</url>
            <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2014-12-23/pdf/FR-2014-12-23.pdf</url>
            <url displayLabel="XML rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2014-12-23/xml/FR-2014-12-23.xml</url>
        </location>
        <accessCondition type="GPO scope determination">fdlp</accessCondition>
        <part type="issue">
            <extent unit="pages">
                <start>76865</start>
                <end>77356</end>
            </extent>
        </part>
        <recordInfo>
            <recordContentSource authority="marcorg">DGPO</recordContentSource>
            <recordCreationDate encoding="w3cdtf">2014-12-23</recordCreationDate>
            <recordChangeDate encoding="w3cdtf">2024-06-02</recordChangeDate>
            <recordIdentifier source="DGPO">FR-2014-12-23</recordIdentifier>
            <recordOrigin>machine generated</recordOrigin>
            <languageOfCataloging>
                <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
            </languageOfCataloging>
        </recordInfo>
        <extension>
            <docClass>FR</docClass>
            <accessId>FR-2014-12-23</accessId>
            <volume>79</volume>
            <issue>246</issue>
        </extension>
    </relatedItem>
</mods>
